Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Sun, Yu, Campisi, Judith, Higano, Celestia, Beer, Tomasz M, Porter, Peggy, Coleman, Ilsa, True, Lawrence, Nelson, Peter S·2012·Nature Medicine

Cited by (791)

Items 601–700 of 791

  1. Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets
    Gi‐Eun Yang, Seo‐Yeong Yoon, Ju‐Seog Lee, Sun‐Hee Leem, Yung Hyun Choi · 2025 · Genes & Genomics
  2. Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip
    Nikolett Lupsa, Erika Héninger, Adeline B. Ding, Cristina Sánchez‐de‐Diego, Katherine J. Vietor, Shannon R. Reese, Aaron Matthew LeBeau, David Kosoff, David J. Beebe, Sheena C. Kerr et al. · 2026 · International Journal of Molecular Sciences
  3. Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance
    Yali Hu, Jingyao Ge, Meiqi Xin, Runqi Guo, Chengsheng Wu, Wenxue Ma · 2026 · Cancer Letters
  4. Regulation of ENPP5, a senescence-associated secretory phenotype factor, prevents skin aging
    Kento Takaya, Kazuo Kishi · 2024 · Biogerontology
  5. DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cells
    Hailong Tang, Mi-Mi Shu, Bo Dai, Li Xu, Baoxia Dong, Guangxun Gao, Xiequn Chen · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
  6. Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing
    Martine Charbonneau, Kelly Harper, Karine Brochu‐Gaudreau, Alexis Perreault, Patrick P. McDonald, Nadia Ekindi‐Ndongo, Claudio Jeldres A, Claire M. Dubois · 2022 · Frontiers in Medicine
  7. ERMP1 Facilitates The Malignant Characteristics of Colorectal Cancer Cells through Modulating PI3K/AKT/β-Catenin Pathway and Localization of GRP78.
    Nasim Rahmani-Kukia, Mozhdeh Zamani, Pooneh Mokaram · 2023 · PubMed Central
  8. Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir
    Marcella Manerba, Marzia Govoni, Ilse Gert Julia Manet, Antoniofrancesco Leale, Antonietta Comparone, Giuseppina Di Stefano · 2019 · Biochimica et Biophysica Acta (BBA) - General Subjects
  9. Stromal androgen signaling governs essential niches in supporting prostate development and tumorigenesis
    June‐Wha Rhee, Yao Mawulikplimi Adzavon, Zijie Sun · 2024 · Oncogene
  10. Chaotic dynamics and optimal therapeutic strategies for Caputo fractional tumor immune model in combination therapy
    Jia Li, Xuewen Tan, Wanqin Wu, Xinzhi Liu · 2024 · Chaos An Interdisciplinary Journal of Nonlinear Science
  11. Control by Viability in a Chemotherapy Cancer Model
    Mustapha Serhani, H. Essaadi, K. Kassara, Ali Boutoulout · 2019 · Acta Biotheoretica
  12. Bifurcation and chaos analysis of tumor growth
    Haiying Liu, Hongli Yang, Nan Liu, Liangui Yang · 2022 · International Journal of Biomathematics
  13. Tumor-Stroma-Interaktionen im Harnblasenkarzinom
    Jiřı́ Hatina, Michaela Kripnerová, J. Tuková, J. Šrámek, Pavel Dvořák, Martin Pešta, Jana Kolaja Dobra, Václav Babuška, J. Racek, Margarita A. Sobol et al. · 2015 · Der Urologe
  14. Perturbed Signaling and Role of Posttranslational Modifications in Cancer Drug Resistance
    Suruchi Aggarwal, Manu Kandpal, Shailendra Asthana, Amit Kumar Yadav · 2017 · Springer eBooks
  15. Systematic integrated analyses of methylomic and transcriptomic impacts of early combined botanicals on estrogen receptor-negative mammary cancer
    Itika Arora, Yuanyuan Li, Manvi Sharma, Michael R. Crowley, David K. Crossman, Shizhao Li, Trygve O. Tollefsbol · 2021 · Scientific Reports
  16. To clear, or not to clear (senescent cells)? That is the question
    Amaia Lujambio · 2016 · Inside the Cell
  17. Controlling secretion to limit chemoresistance
    Athena Georgilis, Jesús Gil · 2016 · Genes & Development
  18. Radiation resistant cancer cells enhance the survival and resistance of sensitive cells in prostate spheroids
    Pavitra Kannan, Marcin Paczkowski, Ana Miar, Joshua Owen, Warren W. Kretzschmar, Serena Lucotti, Jakob Kaeppler, Jianzhou Chen, Boštjan Markelc, Leoni A. Kunz‐Schughart et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Heterogeneity of Cellular Senescence: Subtype‐Specific Mechanisms and the Emerging Role of Plasma Membrane Damage
    Enaam Alghamdi, Keiko Kono · 2025 · Cancer Science
  20. The natural flavonoid dihydromyricetin targets senescent cells via PRDX2 and alleviates age-related diseases
    Qixia Xu, Gaoxiang Li, Heng Zhang, Zhirui Jiang, Xiuxia Gao, Zi Li, Larissa G. P. Langhi Prata, James L. Kirkland, Guilong Zhang, Yu Sun · 2026 · Nature Communications
  21. Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities
    Eun-mi Yu, Min Woo Hwang, Jeanny B. Aragon‐Ching · 2023 · Research and Reports in Urology
  22. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma
    Yuyang Liu, Xin-Li Han, Yuchen Han, Jingyou Bi, Yanan Wu, Dongquan Xiang, Yinglong Zhang, Wenzhi Bi, Meng Xu, Jianxiong Li · 2024 · Gene
  23. Classification of paclitaxel-resistant ovarian cancer cells using holographic flow cytometry through interpretable machine learning
    Xin Lu, Wenlong Xiao, Huanzhi Zhang, Yakun Liu, Xiaoping Li, Pietro Ferraro, Feng Pan · 2024 · Sensors and Actuators B Chemical
  24. A water-soluble probe with p-hydroxybenzyl quaternary ammonium linker for selective imaging in senescent cells
    Zhen Zhen, Shulei Zhu, Jiyu Jin, Lei Wang, Wei Ping Lu · 2020 · Analytica Chimica Acta
  25. Effects of delay in a biological environment subject to tumor dynamics
    Florent Feudjio Kemwoue, Vandi Deli, Hélène Carole Edima, Joseph Marie Mendimi Nkodo, Carlos Lawrence Gninzanlong, Mireille Mbou Dedzo, Jules Tagne Fossi, Jacques Atangana · 2022 · Chaos Solitons & Fractals
  26. IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health
    Hussain Jaffery, Carmen Huesa, Sabarinadh Chilaka, John Cole, James Doonan, Moeed Akbar, Lynette Dunning, K.E. Tanner, Rob vanʼt Hof, Iain B. McInnes et al. · 2023 · Arthritis & Rheumatology
  27. Prediction of fluctuations in a chaotic cancer model using machine learning
    Elaheh Sayari, Sidney Tiago da Silva, Kelly C. Iarosz, Ricardo Luiz Viana, José Danilo Szezech Junior, Antonio Marcos Batista · 2022 · Chaos Solitons & Fractals
  28. Inhibitors of Tumor Angiogenesis
    Adrian Llewellyn Harris, Daniele Generali · 2014 · Elsevier eBooks
  29. Humanized Mouse and Rat PDX Cancer Models
    Fallon K. Noto, Tseten Yeshi Jamling · 2017 · Molecular and translational medicine
  30. Cellular senescence is a central response to cytotoxic chemotherapy in high-grade serous ovarian cancer
    Llilians Calvo, Shuofei Cheng, Michael Skulimowski, Isabelle Clément, Lise Portelance, Yuecheng Zhan, Eurı́dice Carmona, Julie Lafontaine, Manon de Ladurantaye, Kurosh Rahimi et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Cancer-associated fibroblasts: enablers of tumor drug resistance
    Yanting Chen, Wei Xi, Xingyue Lai, Linglin Xiang, Anqi Zeng, Linjiang Song · 2026 · Journal of Translational Medicine
  32. Peritoneal Gene Transfection of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand for Tumor Surveillance and Prophylaxis
    Nasha Qiu, Zhen Zhang, Xuyong Wei, Chang Xu, Xiaolong Jia, Kai Wang, Yunqi Chen, Shuai Wang, Renyi Su, Beini Cen et al. · 2023 · Nano Letters
  33. New insights into cancer pathology learned from the dynamics of cancer‐associated fibroblasts
    Genichiro Ishii · 2024 · Pathology International
  34. Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation
    Benjamin M. Freyter, Mutaz A. Abd Al‐razaq, Markus Hecht, Christian Rübe, Claudia E. Rübe · 2024 · Genes
  35. What Drosophila Can Teach Us About Radiation Biology of Human Cancers
    Tin Tin Su · 2019 · Advances in experimental medicine and biology
  36. miRNAs are now starring in “No Time to Die: Overcoming the chemoresistance in cancer”
    Anmol Bhatia, Atul Kumar Upadhyay, Siddharth Sharma · 2022 · IUBMB Life
  37. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling
    Shuang Yu, Jingjing Ye, Yingqiao Wang, Ting Lu, Yan Liu, Na Liu, Jingru Zhang, Fei Lu, Daoxin Ma, Robert Peter Gale et al. · 2022 · Journal of Biological Chemistry
  38. Cellular senescence: A potential mode of circular RNAs regulating prostate cancer
    Yunpeng Li, Aoyu Fan, Yunyan Zhang, Ziyi Guo, Wei Meng, Wei Xing Pan, Zhongliang Ma, Wei Chen · 2023 · MedComm – Oncology
  39. Trapping of Payne rearrangement intermediates with arylselenide anions
    Michael E. Jung, Daniel L. Sun · 2014 · Tetrahedron Letters
  40. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
    Go J Yoshida, Arata Azuma, Yukiko Miura, Akira Orimo · 2020 · Vide Leaf, Hyderabad eBooks
  41. Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseases
    Qixia Xu, Qiang Fu, Zi Li, Hanxin Liu, Ying Wang, Xu Lin, Ruikun He, Xuguang Zhang, Judith Campisi, James L. Kirkland et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer
    Yongtao Li, Zhicheng Zhou, Yiqun Zhang, Deyong Jia, Ding Wang, Mary C. Reiger, Chad J. Creighton, Peter S. Nelson, Eva Corey, Colm M. Morrissey et al. · 2025 · Oncogene
  43. Nanotechnologies for Enhancing Anti-Tumor Therapies
    Jie Ning, Ge Zhang, Mervat Balash, Li Hong, Ling Zhu · 2022 · OpenNano
  44. Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies
    Mehrdad Hashemi, Mahdi Rezaei, Hadi Rezaeiaghdam, Behdokht Jamali, Zeinab Khazaei Koohpar, Mahsa Tanha, Anahita Bizhanpour, Saba Asadi, Ali Moghadas Jafari, Elaheh Mohandesi Khosroshahi et al. · 2024 · Translational Oncology
  45. From barriers to breakthroughs: Mesoporous silica nanoparticles in targeting the tumor microenvironment
    Adel Mahmoudi Gharehbaba, Fatemeh Soltanmohammadi, Morteza Eskandani, Khosro Adibkia · 2025 · International Journal of Pharmaceutics
  46. High Throughput Detection of Human Neutrophil Peptides from Serum, Saliva, and Tear by Anthrax Lethal Factor-Modified Nanoparticles
    Yuanyuan Zhao, Xu Zhang, Xiangdong Xue, Zhipeng Li, Fei Chen, Shengliang Li, Anil Kumar, Guozhang Zou, Xing‐Jie Liang · 2013 · ACS Applied Materials & Interfaces
  47. The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature.
    Giuseppe Di Bella, Fabrizio Mascia, Biagio Colori · 2013 · PubMed
  48. Enhanced Cryoablative Methodologies
    John M. Baust, Anthony T. Robilitto, Andrew A. Gage, John G. Baust · 2016 · Frontiers in nanobiomedical research
  49. Remodeling the Irradiated Tumor Microenvironment: The Fifth R of Radiobiology?
    Mary Helen Barcellos‐Hoff · 2016 · Cancer drug discovery and develogment/Cancer drug discovery and development
  50. Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment
    Ross A. Vitek, Wei Huang, Peter G. Geiger, Erika Héninger, Joshua Michael Lang, David Frazier Jarrard, David J. Beebe, Brian P. Johnson · 2022 · The Prostate
  51. Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options
    Qiuxing Meng, Yaoming Deng, Yu Lu, Chun‐Feng Wu, Shifu Tang · 2022 · Journal of Cancer Research and Clinical Oncology
  52. Afatinib, a lung cancer inhibitor of ErbB family
    Pasqualino De Antonellis · 2014 · Naunyn-Schmiedeberg s Archives of Pharmacology
  53. Molecular Characterization of Prostate Cancer Following Androgen Deprivation: The Devil in the Details
    Christopher E. Barbieri, Mark A. Rubin · 2013 · European Urology
  54. Mechanisms of Tissue Injury in Cryosurgery
    John G. Baust, Kimberly L. Santucci, Kristi K. Snyder, Anthony T. Robilotto, John M. Baust · 2023
  55. Ganoderic Acid A Suppresses Androgenindependent Cell Growth via the AKT/GSK-3β/β-catenin Signaling Pathway
    Qiao Lyu, Yuan Qu, Jianfan Chen, Guo Chen, Zheng Chen, Lijun Qu · 2024 · Pharmacognosy Magazine
  56. Spatial Reorganization of Chromatin Architecture Shapes the Expression Phenotype of Therapy‐Induced Senescent Cells
    Ge Zhang, Wen Zhang, Changxu Wang, Zhirui Jiang, Qixia Xu, Haipeng Li, James L. Kirkland, Gang Wei, Yu Sun · 2026 · Aging Cell
  57. Bystander response triggered by doxorubicin-killed dead cells contributes to acquire drug resistance but increasing radiosensitivity In vitro
    KaushalaPrasad Mishra, Abhay Puthli, Reeta Tiwari · 2016 · Journal of Radiation and Cancer Research
  58. Ovarian Cancers: Their Varied Origins and Pathologically Implicated Microenvironment
    Yu Sun, Nelly Auersperg · 2018 · Elsevier eBooks
  59. Cancer cell metabolism resulting in multidrug resistance to chemotherapy and possible ways out
    Oluwaseun Fapohunda, Damilola Comfort Ajayi · 2020 · Journal of Cancer Prevention & Current Research
  60. Thymus as Incontrovertible Target of Future Immune Modulatory Therapeutics
    Ghulam Jilany Khan, Abeeha Imtiaz, Wei Wang, Hong Quan Duan, Hui Cao, Kefeng Zhai, Nongyue He · 2024 · Endocrine Metabolic & Immune Disorders - Drug Targets
  61. Commercial and regulatory challenges in cancer nanomedicine
    Sepand Tehrani Fateh, Sahand Tehrani Fateh, Amir Salehi-Najafabadi, Amir Reza Aref · 2024 · Elsevier eBooks
  62. Targeting Senescent Cells to Improve Human Health
    Tobias Wijshake, Jan M. A. van Deursen · 2016 · Healthy ageing and longevity
  63. A System Biology‐Based Approach for Designing Combination Therapy in Cancer Precision Medicine
    S. H. Sabzpoushan · 2020 · BioMed Research International
  64. Pharmacological CDK4/6 inhibition unravels a p53-induced secretory phenotype in senescent cells
    Boshi Wang, Simone M. Brandenburg, Alejandra Hernandez‐Segura, Thijmen van Vliet, Elisabeth M. Jongbloed, Saskia M. Wilting, Naoko Ohtani, Agnes Jager, Marco Demaria · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Gene Therapy with Plasmid DNA
    Yun Liu, Sara Musetti, Leaf Huang · 2021 · Burger's Medicinal Chemistry and Drug Discovery
  66. WNT16 primer
    McLean Williamson, Wilson K. Clements · 2024 · Differentiation
  67. Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review)
    Iva Benešová, Katerina Kalkusova, Yea Kwon, Pavla Táborská, Dmitry Stakheev, Kateřina Krausová, Jitka Smetanová, Andrej Ozaniak, Jiřina Bartůňková, Daniel Smrž et al. · 2025 · International Journal of Oncology
  68. Highly permeable and tumor-selective killing Doxil for efficient cancer therapy
    Yidan Shen, Yiyang Sun, Yangla Xie, Yanpeng Liu, Zile Shao, Siyu Chen, Zhengxing Lian, Chang Xu, Fei Lv, Tong Jinyi et al. · 2025 · Nano Research
  69. Skin aging and immunosenescence
    Nataša Štrbo, Sujad Younis, Daniela Frasca, Alessia Paganelli · 2025 · Exploration of Immunology
  70. Modeling CAF-tumor interactions to overcome therapy resistance
    Jakub Gubała, Daniel A. Benamran, Petros K. Tsantoulis, Valentin Mieville, Massimo Valério, Patrycja M. Nowak-Sliwinska · 2026 · Journal of Experimental & Clinical Cancer Research
  71. Dying cells as architects of the stem cell niche: a conserved mechanism driving tissue regeneration and tumor therapy resistance
    M J Jiang, Yongchao Yu, Zan Jiao, Tong Wu, Kang Ning, Zhongyuan Yang, Wei‐Chao Chen, Ankui Yang · 2026 · Cell Communication and Signaling
  72. Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer
    Taito Miyamoto, Yujie Ye, Marlaine Maged Hosny Soliman, Bryan S. Manning, Brennah Murphy, Linna Zhu, Chunlei Shao, Gauri Mirji, Moeko Minakuchi, Kohei Hamada et al. · 2026 · Journal for ImmunoTherapy of Cancer
  73. Dynamics of cancerous tumors under the effect of delayed information: mathematical and electronic study
    Florent Feudjio Kemwoue, Vandi Deli, Joseph Marie Mendimi Nkodo, Carlos Lawrence Gninzanlong, Jules Tagne Fossi, Jacques Atangana · 2022 · International Journal of Dynamics and Control
  74. Generation of Cancer Stem Cells by Co-Culture Methods
    Biswajit Das, Chanakya Nath Kundu · 2024 · Methods in molecular biology
  75. Establishment of a tumor-associated fibroblast associated gene score based on scRNA-seq to predict prognosis in patients with triple-negative breast cancer
    Hao Yu, Ziqi Peng, Xing Li, Yiqi Zhang · 2024 · PLoS ONE
  76. Network-Based Analysis of Rutin-Induced Gene Expression Changes in Human Senescent Stromal Cells
    Lucia Novakova, Petr Dolezal, Jana HORÁKOVÁ · 2024 · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology
  77. Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma
    Li Yang, Yuling Gao, Weiling Chu, Jianjian Lv, Zhi Li, Tongxin Shi · 2021 · Aging
  78. Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model
    Wenjun Zhao, Lirong Wei, Dongming Tan, Guangsong Su, Yanwen Zheng, Chao He, Zhengwei Jenny Mao, Timothy P. Singleton, Bin Yin · 2014 · PLoS ONE
  79. Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer
    Eszter Podmaniczky, Katalin Fábián, Judit Pápay, Rita Puskás, Márton Gyulai, József Furák, László Tiszlavicz, György Losonczy, József Tı́már, Judit Moldvay · 2014 · Pathology & Oncology Research
  80. Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research
    Srinivas Vourganti, Jeffrey B. Donaldson, Linda Johnson, Barış Türkbey, Gennady Bratslavsky, Leszek Kotula · 2014 · Experimental Biology and Medicine
  81. Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
    Gábor Valcz, Ferenc Sípos, Zsolt Tulassay, Bela Akos Molnar, Yukako Yagi · 2015 · Postgraduate Medical Journal
  82. Cancer-associated fibroblasts as a potential target in oncology therapy
    Agnieszka Dominiak, Tomasz Jerzy Nowicki, Dominika Łacheta, Grażyna Nowicka · 2019 · Postępy Higieny i Medycyny Doświadczalnej
  83. Modifications of WNT signaling pathway genes including WNT1, KLF5 and WNT16 in colorectal cancer
    Seyedeh Elham Norollahi, Seyed Mohammad Taghi Hamidian, Sogand Vahidi, Kosar Babaei, Ali Akbar Samadani · 2020 · Gene Reports
  84. An emerging role of N-glycosylation in cancer chemoresistance
    Yuhan Sun, Tiangui Wu, Jianguo Gu · 2024 · Carbohydrate Research
  85. Senescence-associated secretory phenotype regulation by dual drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy
    Anni Wang, Shiyi Li, Ru Zhang, Xing Chen, Ying Zhu, Jiaxuan Xia, Jianxin Wang · 2024 · Molecular Therapy Oncology
  86. Phenotypic plasticity and lineage switching in prostate cancer
    Jason A. Somarelli, Andrew J. Armstrong, Maya U. Sheth, Kathryn E. Ware, Mohit Kumar Jolly · 2020 · Elsevier eBooks
  87. Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence
    Manizheh Sarikhani, Masoumeh Firouzamandi · 2022 · Molecular Biology Reports
  88. Identification of Genomic Predictors of Response to the CDK4/6 Inhibitor Palbociclib using the UCLATORL Panel of Human Cancer Cell Lines
    Dylan F. Conklin · 2013 · eScholarship (California Digital Library)
  89. Senescent cells develop PDK4-dependent hypercatabolism and form an acidic microenvironment to drive cancer resistance
    Xuefeng Dou, Qilai Long, Shuning Liu, Yejun Zou, Da Fu, Xue Chen, Qixia Xu, Changxu Wang, Xiaohui Ren, Guilong Zhang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines
    Hongwei Zhang, Qixia Xu, Zhirui Jiang, Rong Sun, Sanhong Liu, James L. Kirkland, Weidong Zhang, Yu Sun · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Stemness signatures reflect prognostic disturbances in gastric cancer
    Wenfeng Pu, Xiao Feng Yang, Xiao-Qing Wang, Xiao-Guang Guo, Mi-Yuan Yang · 2025 · World Journal of Gastrointestinal Oncology
  92. Unveiling the role of PGCCs in tumor recurrence and therapeutic resistance: Hidden architects of cancer’s comeback
    Mokhtar Rejili, Farid Hashemi · 2025 · Pathology - Research and Practice
  93. Therapeutic GSK-3β targeting stabilizes multifunctional β-catenin to rescue neuronal and behavioral deficits in fragile X messenger ribonucleoprotein 1 knockout mice
    Siming Zhang, Peng Xiang, Mingjiao Suo, Ziyu Yi, Zhen Wei, Jinquan Li, Yan Zeng, Yushan Chen · 2025 · Brain Research Bulletin
  94. Pharmacological targeting of the senescence-associated secretory phenotype in atherosclerosis: therapeutic potential of senolytics and senomorphics
    Emad Manni, Hayder M. Al‐kuraishy, Mohamed N Fawzy, Gaber El‐Saber Batiha · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  95. Targeted therapy in prostate cancer: is there hope beyond the androgen receptor?
    Joshi J. Alumkal, Julie Nicole Graff, Tomasz M. Beer · 2013 · PubMed
  96. The National Cancer Institute’s Efforts in Promoting Research in the Tumor Microenvironment
    Nastaran Zahir, Elisa C. Woodhouse, Suresh Mohla · 2015 · The Cancer Journal
  97. The Story of Adjuvants to Boost the Performance of Cryoablation
    Kimberly L. Santucci, John M. Baust, Kristi K. Snyder, Anthony T. Robilotto, Robert G. VanBuskirk, John G. Baust · 2017 · Current clinical urology
  98. Landscape and Targeting of the Angpt-Tie System in Current Anticancer Therapy
    LYu Sun, Boyi Zhang · 2015 · Translational Medicine
  99. Updated Landscape of the Tumor Microenvironment and Targeting Strategies in an Era of Precision Medicine
    Yu Sun, Paul J. Chiao · 2017 · InTech eBooks
  100. Reliable prognostic definition and immunotherapy response prediction in bladder cancer, based on a novel aging-associated 5-gene signature model
    Wei Meng, Ningning Li, Bo Chen, Huajun Zhang, Limin Ma, Yangbo Guan · 2024 · Translational Andrology and Urology